News & Updates
See below the latest news updates from HiTech Health
Key Serialisation Considerations for Orphan Drugs
Adapting company strategies to serialisation Falsified medicines are counterfeit drugs that reach the market illegally. They have not been approved and may contain ingredients which are of poor quality and/or at the incorrect dose. Notably, falsified medicines pose...
What will Brexit mean for the pharmaceutical sector?
The UK life sciences industry contributes over £30bn to the UK economy, and supports almost half a million UK jobs. The UK is a leading centre of medical research and biopharmaceutical innovation, and is at the forefront of the drug development and approval process in...
FOUR Key Considerations for Scaling-up BioPharma Products
A BioPharma product may go through a scaling process multiple times during its life cycle. The product owner may decide to either select a Contract Manufacturing Organisation (CMO) to manufacture a product or manufacture in-house. The first batches manufactured in a...